Home / Import refusals / BJE-0117438-3/1/1

BJE-0117438-3/1/1

Hospira, Inc. — FEI 1925262

Recent inspections

  • 1255699 (VAI Fri Jan 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1229140 (NAI Wed Mar 27 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1115467 (VAI Fri Jan 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1064827 (OAI Wed Aug 15 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1031233 (VAI Fri Oct 27 2017 00:00:00 GMT+0000 (Coordinated Universal Time))

Compliance actions

Other import refusals

  • 9SN-0007009-6/81/1 (Mon Feb 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 9SN-0007009-6/71/1 (Mon Feb 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 9SN-0007009-6/21/1 (Mon Feb 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 8JB-0093850-4/11/15 (Wed Mar 22 2023 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 8JB-0093850-4/11/47 (Wed Mar 22 2023 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

Refusal Details

Date
April 20, 2011
Country
United States
Product Category
Drugs and Biologics
Product Code
62OCP24 DILTIAZEM HYDROCHLORIDE (ANTI-HYPERTENSIVE - PART II)
Charges
27